A broad proposal by Medicare to change the way it pays for some drugs has drawn intense reaction and lobbying, with much of the debate centering on whether the plan gives too much power over drug prices to government regulators

Quick Read

The price of drugs is the U.S. public’s top health-care concern in opinion polls, and the 2016 presidential candidates are increasingly paying attention

Quick Read